Dennis M. Zimmerman

Synthesis and Evaluation of a Series of Novel 2-[(4-Chlorophenoxy)methyl]- benzimidazoles as Selective Neuropeptide Y Y1 Receptor Antagonists

Hamideh Zarrinmayeh, Anne M. Nunes, Paul L. Ornstein et al. · Journal of Medicinal Chemistry · 1998 · 153 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of a Potent, Peripherally Selective trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonist for the Treatment of Gastrointestinal Motility Disorders

Dennis M. Zimmerman, J. S. Gidda, Buddy E. Cantrell et al. · Journal of Medicinal Chemistry · 1994 · 118 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of the First <i>trans</i>-(3<i>R</i>,4<i>R</i>)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity

James B. Thomas, Robert N. Atkinson, Richard B. Rothman et al. · Journal of Medicinal Chemistry · 2001 · 106 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson’s Disease

Tracey K. Murray, Katherine Whalley, Christine S. Robinson et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 106 citations

Life Sciences, Neuroscience, Pharmacology +16

Anticonvulsant effects of phencyclidine-like drugs: relation to N-methyl-d-aspartic acid antagonism

J. David Leander, Robert C. Rathbun, Dennis M. Zimmerman · Brain Research · 1988 · 101 citations

Medicine, Neuroscience, Pharmacology +9